Pennsylvania-based Conestoga Capital Advisors sold 855,435 Vertex shares for an estimated $24.8 million ... of securities a fund manager must disclose quarterly to the SEC on Form 13F. Reduction (in ...

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results ...

Apacer (TWSE: 8271), a global leader in industrial memory and storage solutions, will showcase its latest innovations at embeddedworld North America 2025. Visitors will explore Apacer's advancements ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Mr. Quigley most recently led McKinsey & Company’s Private Capital practice and previously led various Life Sciences practices at the ...

The startup is advancing a drug licensed from China’s Hengrui Pharma that it claims could be “best-in-class” among a group of ...

Among 27 men who received 25 mL to 1.5 L of a water-like liquid known as perfluorodecalin, 20 were able to retain it within ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all.